Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.61
+0.11 (1.69%)
At close: Mar 9, 2026, 4:00 PM EDT
6.61
0.00 (0.00%)
After-hours: Mar 9, 2026, 7:00 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $384.75 million as of March 9, 2026. Its market cap has decreased by -36.59% in one year.
Market Cap
384.75M
Enterprise Value
402.02M
1-Year Change
-36.59%
Ranking
Category
Stock Price
$6.61
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $384.75M, a decrease of -82.37%. That is a compound annual growth rate of -29.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 378.35M | -19.89% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enanta Pharmaceuticals | 392.92M |
| PepGen | 390.83M |
| Benitec Biopharma | 388.45M |
| Armata Pharmaceuticals | 385.91M |
| Monopar Therapeutics | 384.98M |
| Shattuck Labs | 379.05M |
| Aclaris Therapeutics | 369.02M |
| LENZ Therapeutics | 365.15M |